Detroit, MI
Alerje develops an emergency medicine and digital oral immunotherapy management platform to improve the quality of life for those affected by food allergies. Its online platform and app enable users to create food allergy profiles, share the profiles, filter recipes based on the profiles, and also scan grocery items to detect allergens in the ingredients. It also features an epinephrine auto-injector that integrates into a smartphone case for improved patient adherence and alerts, and its National Science Foundation (NSF) validated food allergy oral immunotherapy (OIT) adherence platform collects, stores, analyzes, and distributes alerts and notifications.
alerje.comThese are collections Alerje is a part of. Click on the collection name to view similar companies.
Grant
$1,000,000
Grant
$255,331
Grant
$50,000
Seed
$1,000,000
Pre Seed
$30,000
Grant
$250,000
Grant
$25,000
Pre Seed
$410,000
Grant
$40,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alerje.